Memorial Sloan Kettering Cancer Center’s Post

A team led by Dr. Gaetano Rocco, a thoracic surgeon at Memorial Sloan Kettering Cancer Center (MSK), reported promising results in a clinical trial that tested a screening method known as “E-nose." The E-nose uses technology that can “smell” lung cancer in a person’s breath. "Chemicals called volatile organic compounds (VOCs) are emitted by cancer cells,” Dr. Rocco explains. “And they can be detected even at early stages of the disease.” The trial raises hopes that E-nose could become an important tool in detecting lung cancer because the approach is noninvasive, highly accurate, inexpensive — and may one day even be small enough to slip inside a clinician’s pocket. "E-nose could be a valuable addition to diagnosing and treating lung cancer,” he says, “and MSK’s expertise and leadership in the field means it’s the right place to make this a reality.” Learn more: https://bit.ly/4bONjjp

  • No alternative text description for this image

We would like to inform you that your post has been successfully published on Oncodaily. Thank you for sharing! https://oncodaily.com/blog/110485.html

Like
Reply
PD Dr. med. Steffen Frese

Chefarzt Klinik für Thoraxchirurgie

1mo

I am completely confused by the conclusion of the paper. Obviousely, from 100 probes, the e-nose classified 98 probes as positive (including the 12 patients with no lung cancer). In a cohort with 88 lung cancer patients. My question, where is an appropriate control group tested negative for lung cancer? And if the e-nose measured almost all probes positive, how the authors came to the conclusion that it works?

incredible innovation! excited to follow this trial's progress!

Like
Reply

Excellent project, when technology is used for human well-being. I would like to follow the results of this excellent trial. I have met several relatives of patients with lung cancer who have told me that they smell a peculiar smell that they cannot define, but they feel it. That's what they told me. Congratulations to the researchers of this excellent project.

Like
Reply

Wow! This is truly amazing.

Like
Reply
Evangelos Koliakos, MD

Swiss Board-Certified General Surgeon FMH, Clinical Fellow In Minimally Invasive Thoracic Surgery and Lung Transplantation in Montreal University Hospital CHUM

1mo

Congratulations, amazing work Professor! Really excited to be able to discuss more in detail during my upcoming observership in MSK!

GianPietro Sabini

Data Scientist AI Lecturer | Former Fixed Income trader | Former Instructor at Columbia University,{among other things} Never Despair, life is short ...climb a mountain, eat a peach!

1mo

VOC's can be used to detect many illnesses. I was interested in Covid, however the issues were not only engineering, that was the easy part. VOC's from Delta and Omega variants can confound the sensor. It was a difficult thing to unknot. Congratulations for MSK Dr. Rocco. Complimenti!

Like
Reply
Cinzia Sevignani, Ph.D.

Associate Professor of Instruction in Cell & Molecular Biology, Anatomy & Physiology, Genetics, Mol. Diagnost., Education Researcher and Art Designer. Passionate and Enthusiastic about Art, Design, Humanity and Sciences.

1mo

This would amazing! Sadly my classmate recently passed away because of lung cancer. I am still thinking of her 🙏 Can they detect all types? Thank you for sharing.

Like
Reply
Corey Lucius, MS, FNP-C

Board Certified Family Nurse Practitioner • primary care • telemedicine • thoracic medical & surgical oncology • hospital medicine

1mo

Dr. Rocco is the man! Smart, caring, talented surgeon.

See more comments

To view or add a comment, sign in

Explore topics